IFNG and neoplasm: A common form of intravesical therapy is BCG, and several mechanisms are thought to trigger local immune response following intravesical BCG administration, such as increased levels of urinary cytokine, elevated expression of interferon gamma, and inhibition of tumor growth (64, 65).